26 research outputs found
Development of Potential Multi-Target Inhibitors for Human Cholinesterases and Beta-Secretase 1: A Computational Approach
Alzheimer’s disease causes chronic neurodegeneration and is the leading cause of dementia
in the world. The causes of this disease are not fully understood but seem to involve two essential
cerebral pathways: cholinergic and amyloid. The simultaneous inhibition of AChE, BuChE, and
BACE-1, essential enzymes involved in those pathways, is a promising therapeutic approach to treat
the symptoms and, hopefully, also halt the disease progression. This study sought to identify triple
enzymatic inhibitors based on stereo-electronic requirements deduced from molecular modeling
of AChE, BuChE, and BACE-1 active sites. A pharmacophore model was built, displaying four
hydrophobic centers, three hydrogen bond acceptors, and one positively charged nitrogen, and
used to prioritize molecules found in virtual libraries. Compounds showing adequate overlapping
rates with the pharmacophore were subjected to molecular docking against the three enzymes and
those with an adequate docking score (n = 12) were evaluated for physicochemical and toxicological
parameters and commercial availability. The structure exhibiting the greatest inhibitory potential
against all three enzymes was subjected to molecular dynamics simulations (100 ns) to assess the
stability of the inhibitor-enzyme systems. The results of this in silico approach indicate ZINC1733
can be a potential multi-target inhibitor of AChE, BuChE, and BACE-1, and future enzymatic assays
are planned to validate those results.PPBE and PPGCF/UEFS; Fundação de Amparo à Pesquisa
do Estado de Minas Gerais—FAPEMIG, grants APQ-02741-17, APQ-00855-19, APQ-01733-21, and
APQ-04559-22Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq-Brazil,
grants 305117/2017-3, 426261/2018-6Fellowship of 2021 (grant 310108/2020-9
Comparative Genomic Analysis of Human Fungal Pathogens Causing Paracoccidioidomycosis
Paracoccidioides is a fungal pathogen and the cause of paracoccidioidomycosis, a health-threatening human systemic mycosis endemic to Latin America. Infection by Paracoccidioides, a dimorphic fungus in the order Onygenales, is coupled with a thermally regulated transition from a soil-dwelling filamentous form to a yeast-like pathogenic form. To better understand the genetic basis of growth and pathogenicity in Paracoccidioides, we sequenced the genomes of two strains of Paracoccidioides brasiliensis (Pb03 and Pb18) and one strain of Paracoccidioides lutzii (Pb01). These genomes range in size from 29.1 Mb to 32.9 Mb and encode 7,610 to 8,130 genes. To enable genetic studies, we mapped 94% of the P. brasiliensis Pb18 assembly onto five chromosomes. We characterized gene family content across Onygenales and related fungi, and within Paracoccidioides we found expansions of the fungal-specific kinase family FunK1. Additionally, the Onygenales have lost many genes involved in carbohydrate metabolism and fewer genes involved in protein metabolism, resulting in a higher ratio of proteases to carbohydrate active enzymes in the Onygenales than their relatives. To determine if gene content correlated with growth on different substrates, we screened the non-pathogenic onygenale Uncinocarpus reesii, which has orthologs for 91% of Paracoccidioides metabolic genes, for growth on 190 carbon sources. U. reesii showed growth on a limited range of carbohydrates, primarily basic plant sugars and cell wall components; this suggests that Onygenales, including dimorphic fungi, can degrade cellulosic plant material in the soil. In addition, U. reesii grew on gelatin and a wide range of dipeptides and amino acids, indicating a preference for proteinaceous growth substrates over carbohydrates, which may enable these fungi to also degrade animal biomass. These capabilities for degrading plant and animal substrates suggest a duality in lifestyle that could enable pathogenic species of Onygenales to transfer from soil to animal hosts.National Institute of Allergy and Infectious Diseases (U.S.)National Institutes of Health. Department of Health and Human Services (contract HHSN266200400001C)National Institutes of Health. Department of Health and Human Services(contract HHSN2722009000018C)Brazil. National Council for Scientific and Technological Developmen
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle?
The age-related epithelial cancers of the breast, colorectum and prostate are the most prevalent and are increasing in our aging populations. Epithelial cells turnover rapidly and mutations naturally accumulate throughout life. Most epithelial cancers arise from this normal mutation rate. All elderly individuals will harbour many cells with the requisite mutations and most will develop occult neoplastic lesions. Although essential for initiation, these mutations are not sufficient for the progression of cancer to a life-threatening disease. This progression appears to be dependent on context: the tissue ecosystem within individuals and lifestyle exposures across populations of individuals. Together, this implies that the seeds may be plentiful but they only germinate in the right soil. The incidence of these cancers is much lower in Eastern countries but is increasing with Westernisation and increases more acutely in migrants to the West. A Western lifestyle is strongly associated with perturbed metabolism, as evidenced by the epidemics of obesity and diabetes: this may also provide the setting enabling the progression of epithelial cancers. Epidemiology has indicated that metabolic biomarkers are prospectively associated with cancer incidence and prognosis. Furthermore, within cancer research, there has been a rediscovery that a switch in cell metabolism is critical for cancer progression but this is set within the metabolic status of the host. The seed may only germinate if the soil is fertile. This perspective brings together the different avenues of investigation implicating the role that metabolism may play within the context of post-genomic concepts of cancer